Cinryze 500 IE

Cinryze 500 IE is a medicine authorised by Swissmedic under authorisation number 61636. The authorisation holder is Takeda Pharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 May 2013 and the authorisation is limited until 31 August 2026. ATC code B06AC01 places the medicine in the group Other hematological agents.

Dispensing category B
Authorisation number 61636
ATC B06AC01
Blood products

Authorisation data
Authorisation number	61636
Name	Cinryze 500 IE
Full name	Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holder	Takeda Pharma AG
Medicinal product code	Blood products
Dispensing category	B · Prescription only
ATC code	B06AC01
First authorisation	23 May 2013
Authorisation validity	31 August 2026

Strengths
No.	Name	Dispensing category	Authorisation date
1	Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	23 May 2013

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
2		2 Fl. à 500 IE/UI Pulver + 2 Fl. à 5 ml Lösungsmittel und Verabreichungsset	B06AC01	06.01.1.	B

Scroll the table sideways

Medicines in the same ATC group

Berinert IV 500Authorisation number 51950 · CSL Behring AG · ATC B06AC01B Berinert SC 2000 IUAuthorisation number 67519 · CSL Behring AG · ATC B06AC01B

Other medicines from this authorisation holder

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05A Advate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02B Adynovi 250 IE (5 ml)Authorisation number 65953 · ATC B02BD02B Adzynma 500 I.E.Authorisation number 69562 · ATC B01AD13B Agopton 30 mgAuthorisation number 51969 · ATC A02BC03B Alunbrig 30 mgAuthorisation number 66738 · ATC L01ED04A Ceprotin 500 I.E.Authorisation number 56124 · ATC B01AD12B Cuvitru 200 mg/mlAuthorisation number 65992 · ATC J06BA01B

Frequently asked questions

Is Cinryze 500 IE authorised in Switzerland?

Yes. Cinryze 500 IE is authorised by Swissmedic under authorisation number 61636, data as of 01 September 2026. The authorisation is limited until 31 August 2026.

Which dispensing category does Cinryze 500 IE have?

Cinryze 500 IE is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Cinryze 500 IE?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.